Medix Biochemica CEO (Chief Executive Officer) refutes N-Dia PROM (premature rupture of foetal membrane) claims
This article was originally published in Clinica
Executive Summary
Medix Biochemica, the Finnish rapid test maker, has defended its decision to sue US firm N-Dia for infringing a patent covering diagnostic methods and test kits for detecting premature rupture of foetal membrane (PROM).